CytoDyn to Hold Webcast and Live Q/A on December 14

NEXT STORY
Roche presents pivotal data at ASH 2021 for novel cancer immunotherapy mosunetuzumab
PREV STORY
Merus présente une analyse actualisée du zenocutuzumab, du trastuzumab et de la vinorelbine chez des patientes atteintes d’un cancer du sein métastatique HER2+ lors du Symposium sur le cancer du sein de San Antonio
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aileron Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

CAMBRIDGE, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), the clinical-stage leader ...

author_avatar
NASDAQ Market News

NEOVACS ANNOUNCES THE RESULTS OF ITS PHASE IIB STUDY FOR IFNalpha KINOID IN THE TREATMENT OF LUPUS

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE RESULTS OF ITS ...

author_avatar
NASDAQ Market News

Argos Therapeutics to Participate in SITC 2016 Annual Meeting

DURHAM, N.C., Nov. 10, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an ...

author_avatar
NASDAQ Market News